Literature DB >> 14150741

ANTINUCLEAR FACTOR IN SYSTEMIC LUPUS ERYTHEMATOSUS. A CONSIDERATION OF THE IMMUNOFLUORESCENT METHOD OF DETECTING ANTINUCLEAR ANTIBODIES, WITH RESULTS OBTAINED IN A FAMILY STUDY.

J HOLBOROW, G D JOHNSON.   

Abstract

Keywords:  ANTIBODIES; ANTIGENS; ARTHRITIS, JUVENILE RHEUMATOID; ARTHRITIS, RHEUMATOID; CLINICAL RESEARCH; FLUORESCENT ANTIBODY TECHNIC; GAMMA GLOBULIN; GENETICS, HUMAN; IMMUNE SERUMS; IMMUNOELECTROPHORESIS; LE CELLS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICROSCOPY, FLUORESCENCE

Mesh:

Substances:

Year:  1964        PMID: 14150741     DOI: 10.1002/art.1780070204

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  10 in total

1.  LUPUS ERYTHEMATOSUS, SYSTEMIC SCLERODERMA AND DERMATOMYOSITIS.

Authors:  C J MCDONALD; R W TURNER
Journal:  J Natl Med Assoc       Date:  1965-01       Impact factor: 1.798

2.  Serum autoantibodies in hepatitis associated antigen (HAA) positive patients. A possible index of cell-mediated immunity to the associated-infective agent.

Authors:  F J Dudley; M J O'Shea; S Sherlock
Journal:  Clin Exp Immunol       Date:  1973-03       Impact factor: 4.330

3.  Serum autoantibodies and immunoglobulins in hepatitis-associated antigen (HAA)-positive and -negative liver disease.

Authors:  F J Dudley; M J O'Shea; A Ajdukiewicz; S Sherlock
Journal:  Gut       Date:  1973-05       Impact factor: 23.059

4.  Immunological sex differences. A study of patients with rheumatoid arthritis, their relatives, and controls.

Authors:  K Rhodes; A Scott; R L Markham; M E Monk-Jones
Journal:  Ann Rheum Dis       Date:  1969-03       Impact factor: 19.103

5.  [Fluorescence microscopic demonstration of antinuclear factors in lupus erythematosus and related diseases].

Authors:  K Havemann; P Arend
Journal:  Klin Wochenschr       Date:  1966-01-01

6.  Delayed hypersensitivity in systemic lupus erythematosus.

Authors:  S R Block; C B Gibbs; M B Stevens; L E Shulman
Journal:  Ann Rheum Dis       Date:  1968-07       Impact factor: 19.103

7.  Inhibition of antinuclear factor reaction by chloroquine.

Authors:  G Bencze; G D Johnson
Journal:  Immunology       Date:  1965-08       Impact factor: 7.397

8.  Primary liver cell carcinoma complicating autoimmune chronic active hepatitis.

Authors:  A W Jakobovits; P R Gibson; F J Dudley
Journal:  Dig Dis Sci       Date:  1981-08       Impact factor: 3.199

9.  An interplay of genetic and environmental factors in familial hepatitis and myasthenia gravis.

Authors:  S Whittingham; I R Mackay; Z S Kiss
Journal:  Gut       Date:  1970-10       Impact factor: 23.059

10.  Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection.

Authors:  G V Gregorio; P Pensati; R Iorio; A Vegnente; G Mieli-Vergani; D Vergani
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.